|Bid||0.00 x 1100|
|Ask||0.00 x 1300|
|Day's Range||11.45 - 12.47|
|52 Week Range||8.23 - 28.60|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 15, 2022 - Nov 21, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||38.00|
Shares of Nano-X Imaging (NASDAQ: NNOX), commonly called Nanox, soared on Wednesday after it revealed it's taken the next step toward commercializing its flagship medical device. As of 12:20 p.m. ET, Nanox stock was up 21%. Nanox had its initial public offering (IPO) in 2020, promising to disrupt the X-ray industry with its digital-3D imaging machines that will be cheaper for doctors to use.
NEVE ILAN, Israel, Sept. 08, 2022 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, today announces that Company management will participate in two investor conferences in the month of September 2022: LifeSci Partners HealthTech Symposium on September 20-21, 2022Ladenburg Thalmann Healthcare Conference on September 29, 2022 About LifeSci Partners HealthTech Symposium Nanox’s Chief Executive Officer, Erez Meltzer, an
One of the big advantages individual investors have over fund managers is that no one is looking over their shoulders for quick results. In this roundtable, three Motley Fool contributors picked healthcare stocks that they believe will be big winners for a long time. Here's why they recommend OrthoPediatrics (NASDAQ: KIDS), Compass Pathways (NASDAQ: CMPS), and Nano-X Imaging (NASDAQ: NNOX).